Shares in Strides Arcolab Ltd rose more than 5 per cent after the company said it has received US FDA approval for generic version of Gemcitabine injection used in the treatment of cancer,dealers said. At about 10 am shares were up 3.81 per cent to 381.55 rupees in a flat Mumbai market.
Company INFO
You’ve Read Your Free Stories For Now
Sign up and keep reading more stories that matter to you.
